Even though a growing number of studies have demonstrated that EGFR-stimulated cancer growth depends on SCD1 activity especially in lung adenocarcinoma, no investigations have been carried out to identify the relevance of SCD1 expression linked to EGFR-TKI resistance in lung adenocarcinoma. The gene discussed is SCD; the disease is cancer.